Meghan FitzGerald is a global healthcare strategist, investor, academic, and author. A highly regarded expert, she has worked in every domain of healthcare—from front-line patient care to Fortune 500—all while serving as an adjunct professor at Columbia University
Currently, Ms. FitzGerald is a private equity investor where she is an advisor to several firms, including Goldman Sachs and Wellspring Capital. Prior to this, Ms. FitzGerald was the chief executive officer and managing partner at Letter One’s inaugural health vehicle, where she allocated approximately $4 billion in 3 years within pharmaceutical services and animal health. Ms. FitzGerald has spent nearly 20 years as an operator and strategist, working for many prominent healthcare firms, including Merck, Pfizer, and Medco. She was also the executive vice president of strategy, mergers and acquisitions, and health policy at Cardinal Health, and a member of the executive committee. In addition to her board appointment at Quanta, Ms. FitzGerald is a member of the board of directors at Tenet Healthcare.